Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. August 2008 07:00 ET | Quelle: Eurand N.V.

Eurand Reports Recent Developments and Second Quarter 2008 Financial Results

Highlights: * Received approvable letter for New Drug Application (NDA) for EUR-1008 (Zentase(r)) * Achieved successful FDA pre-approval inspection of Milan manufacturing facility...
06. August 2008 08:55 ET | Quelle: Eurand N.V.

Eurand to Receive $35 Million Payment in Litigation Settlement

DAYTON, Ohio, Aug. 6, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) today announced that Eurand Inc. and UCB, Inc. have settled long-running litigation concerning a 1999 development, license and...
01. August 2008 09:45 ET | Quelle: Eurand N.V.

Eurand Enters Agreement With Daewoong Pharmaceutical Co. Ltd (South Korea) for Once-Daily Extended Release Muscle Relaxant

PHILADELPHIA, Pa., Aug. 1, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
18. Juli 2008 08:00 ET | Quelle: Eurand N.V.

Eurand Announces Conference Call On Second Quarter 2008 Financial Results

AMSTERDAM, The Netherlands, July 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
16. Juli 2008 16:11 ET | Quelle: Eurand N.V.

Eurand Industrial Award Honors Achievement in Drug Delivery Research

MILAN, Italy, July 16, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) and the Controlled Release Society (CRS) announced today that the 2008 Eurand Industrial Award has been presented to...
10. Juli 2008 08:00 ET | Quelle: Eurand N.V.

Eurand Names Bill Newbould Vice President, Investor Relations

PHILADELPHIA, July 10, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
18. Juni 2008 16:05 ET | Quelle: Eurand N.V.

Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase)

PHILADELPHIA, June 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
03. Juni 2008 09:00 ET | Quelle: Eurand N.V.

Eurand to Be Issued U.S. Patent for Amrix(r)

DAYTON, Ohio, June 3, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...
20. Mai 2008 08:00 ET | Quelle: Eurand N.V.

Eurand to Present At UBS Global Specialty and Generic Pharmaceuticals Conference

AMSTERDAM, May 20, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical...
15. Mai 2008 16:00 ET | Quelle: Eurand N.V.

Eurand Announces Annual General Meeting of Shareholders Date of May 30, 2008

AMSTERDAM, The Netherlands, May 15, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and...

Vorherige Seite

Nächste Seite